Preliminary results of BEAVER: An investigator-initiated phase II study of binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts).April A. N. Rose,Olubukola Ayodele,Sofia Genta,Thiago Pimentel Muniz,Deirdre Kelly,Kelsey Hodgson,Ian King,Tracy Stockley,Trevor J. Pugh,Zaid Saeed Kamil,Marcus O. Butler,Frances A. Shepherd,Philippe L. Bedard,Natasha B. Leighl,Albiruni Ryan Abdul Razak,Aaron Richard Hansen,Samuel Saibil,David W. Cescon,Lillian L. Siu,Anna SpreaficoJOURNAL OF CLINICAL ONCOLOGY（2021）引用 2|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
